OC 61.3 CS585 is a Novel and Highly Selective IP Receptor Agonist for Prevention of ThrombosisSylviane Lambert, Michael Holinstat, Livia Stanger et al.|Research and Practice in Thrombosis and Haemostasis|2023Cited by 0
Superiority of CS585 as a selective prostacyclin receptor agonist in prevention of thrombosisLivia Stanger, Michael Holinstat, Björn Dahlöf et al.|European Heart Journal|2023Cited by 0